Document is current
Any future updates will be listed below
-
Authors
Thomassen, Doranne
Roychoudhury, Satrajit
Amdal, Cecilie Delphin
Reynders, Dries
Musoro, Jammbe Z.
Sauerbrei, Willi
Goetghebeur, Els
le Cessie, Saskia
,
Kamalakar, Rajesh
Sail, Kavita
Basch, Ethan
Reijneveld, Jaap
Keating, Karen
Su, Yun
Alanya, Ahu
Rumpold, Gerhard
Sasseville, Maxime
Black, Jennifer
Molenberghs, Geert
Rantell, Khadija
Schlichting, Michael
Regnault, Antoine
Ness, David
ten Seldam, Silene
Reksten, Tove Ragna
Schiel, Anja
Falk, Ragnhild Sorum
Campbell, Alicyn
Cappelleri, Joseph C.
Russell-Smith, Alexander
Calvert, Melanie
Cruz Rivera, Samantha
Aiyegbusi, Olalekan Lee
Liu, Limin
Van Lancker, Kelly
Rutherford, Claudia
Bhatnagar, Vishal
Chen, Ting-Yu
Fiero, Mallorie
Kluetz, Paul
- License Information
-
More Information
Article History
Received: 8 April 2024
Accepted: 7 November 2024
First Online: 23 November 2024
Declarations
:
: No data were collected for the purpose of this study. Anonymized data from a previously published trial were shared with us for the illustration of analysis methods, respecting the informed consent previously provided by the trial participants.
: Not applicable.
: Satrajit Roychoudhury, is an employee of Pfizer Inc., and a stockholder of Pfizer Inc. and Novartis Pharmaceutical. Els Goetghebeur and Dries Reynders contribute to a university-based statistical consulting service that has received limited consulting fees from Pfizer, no personal fees. There are no other potential conflicts of interests among the authors.
